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The hippocampus is an integral brain region for
affective disorders. TRIP8b knockout mice lacking
functional HCN channels as well as both HCN1 and
HCN2 knockout mice have been shown to display
antidepressant-like behaviors. The mechanisms
or brain regions involved in these alterations in
behavior, however, are not clear.Wedeveloped a len-
tiviral shRNA system to examine whether knock-
down of HCN1 protein in the dorsal hippocampal
CA1 region is sufficient to produce antidepressant-
like effects. We found that knockdown of HCN1
channels increased cellular excitability and resulted
in physiological changes consistent with a reduction
of Ih. Rats infused with lentiviral shRNA-HCN1 in the
dorsal hippocampal CA1 region displayed antide-
pressant- and anxiolytic-like behaviors associated
with widespread enhancement of hippocampal
activity and upregulation of BDNF-mTOR signaling
pathways. Our results suggest that HCN1 protein
could be a potential target for treatment of anxiety
and depression disorders.
INTRODUCTION
The limbic-cortical system in the brain is considered to be the
neural substrate for the action of antidepressants (Mayberg,
1997; Mayberg et al., 2000). Chronic administration of antide-
pressant drugs in depressed patients changed regional glucose
metabolism measured by positron emission tomography in the
hippocampus (Kennedy et al., 2001; Mayberg et al., 2000). There
are several lines of evidence suggesting that dorsal hippo-
campus is an integral brain region for the action of antidepres-
sants (Lu et al., 2006; McLaughlin et al., 2007; Padovan and
Guimara˜es, 2004). Functional neuroimaging of depressed
patients has shown that the volume of posterior hippocampus,
which corresponds to the dorsal hippocampus in rodents
(Colombo et al., 1998), was significantly reduced (Campbell
et al., 2004), resulting in impaired spatial learning and memory
(Gould et al., 2007). It is often observed that patients withdepression also have anxiety-like symptoms (Jacobi et al.,
2004; Lamers et al., 2011). This comorbidity of depression and
anxiety disorders in some patients was effectively treated with
chronic administration of fluoxetine (Sonawalla et al., 2002). In
addition, mice chronically injected with fluoxetine displayed anti-
depressant- and anxiolytic-like behaviors (Dulawa et al., 2004),
suggesting depression and anxiety might share common neural
substrates.
It has been reported that brain-derived neurotrophic factor
(BDNF) protein expression in the hippocampus of postmortem
depressed patients was significantly reduced (Dwivedi et al.,
2003), and this can be reversed by antidepressant treatments
(Chen et al., 2001), suggesting an important role of BDNF in
major depression. Studies in animals also have shown that
BDNF and mammalian target of rapamycin (mTOR) signaling
pathways are important for antidepressant effects of ketamine
(Autry et al., 2011; Li et al., 2010). A single subanesthesia dose
of ketamine (i.p. 10  15 mg/kg) produced early onset and
long lasting therapeutic antidepressant-like effects, which
required upregulation of BDNF-mTOR signaling pathways and
suggesting a cellular mechanism underlying the antidepres-
sant-like effects of ketamine (Autry et al., 2011; Duman and
Monteggia, 2006; Li et al., 2010, Liu et al., 2012).
Voltage-gated ion channels are non-uniformly distributed in
the CA1 pyramidal neurons (Magee, 1999b). They regulate the
processing of input information and the induction of synaptic
plasticity (Frick and Johnston, 2005). Membrane currents gener-
ated by hyperpolarization-activated, cyclic nucleotide gated
nonselective cation channels (h channels) are characterized by
(1) cyclic nucleotide-mediated modulation, (2) Na+ and K+
permeability, and (3) activation by membrane hyperpolarization
(Pape, 1996). Although there are four isoforms of HCN channels
(HCN1–HCN4), HCN1 is the predominant isoform expressed in
hippocampus, neocortex, and cerebellar cortex (Brewster
et al., 2007; Monteggia et al., 2000). In the hippocampal CA1
region, the expression of HCN1 shows a gradient of increasing
channel density from the soma to the distal apical dendrites
(Lo¨rincz et al., 2002). This is consistent with an increase in Ih
density by cell-attached recordings across the somatodendritic
compartments (Magee, 1998). A portion of h channels is active at
rest leading to the generation of a depolarizing noninactivating
inward current that contributes to the resting membrane poten-
tial, input resistance (Rin), and membrane time constant (tm) of
CA1 pyramidal neurons. Ih also contributes to the intrinsicNeuron 75, 503–516, August 9, 2012 ª2012 Elsevier Inc. 503
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Figure 1. Lentivirus Expressing shRNA-
HCN1 in the CA1 Region of Dorsal Hippo-
campus
(A) A schematic diagram showing the lentiviral
shRNA expression vector system. The 19 nucleo-
tide shRNA is specific to the HCN1 gene. In dual
promoter vector system, shRNA is under control of
U6 promoter and GFP is controlled by synapsin1
promoter.
(B) Expression of lentivirus over time in the dorsal
CA1 region. Rats infused with lentivirus in the
dorsal hippocampal CA1 region were trans-
cardially perfused on day 7, 10, 28, and 180 after
infusion (days post infusion, DPI). The ages of
animals are in parentheses (postnatal day).
(C) Distribution of lentivirus in the dorsal hippo-
campal CA1 region. A single infusion of lentivirus
spread out mediolaterally (about 0.7– 1.0 mm) and
anteroposteriorly (about 1.2–1.6 mm). The arrow
indicates the injection track. DH, dorsal hippo-
campus; VH, ventral hippocampus.
See also Figure S1.
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HCN1 Silencing Reduces Anxiety and Depressionresonance properties, which influence how CA1 neurons
respond to oscillating inputs (Hu et al., 2002; Narayanan and
Johnston, 2007). Blockade of Ih by Cs
+ or ZD7288 enhances
synaptic summation, indicating a key role in the integration of
subthreshold synaptic inputs (Magee, 1999a). Loss of functional
Ih by deletion of the HCN1 gene causes a change in behavioral
phenotypes (Nolan et al., 2003, 2004). Global HCN1 knockout
mice showed impaired motor learning and memory (Nolan
et al., 2003), whereas forebrain-specific HCN1 knockout mice
displayed improved short- and long-term spatial learning and
memory (Nolan et al., 2004).
A recent report demonstrated that reduction of Ih in three
different lines of knockout mice (TRIP8b, HCN1, and HCN2)
showed antidepressant-like behaviors, suggesting that reduc-
tion of h-channel function might result in antidepressant effects
(Lewis et al., 2011). However, the mechanisms or brain regions
underlying these effects are unknown. Given the lack of HCN1-
specific blockers or genetic animal models that offer region-
specific manipulation of HCN1 channels, we developed a
lentiviral shRNA system that provides sequence-specific manip-
ulation of HCN1 with spatial and temporal control (Elbashir et al.,
2001). We found that shRNA-HCN1-infected dorsal CA1 pyra-
midal neurons had altered intrinsic membrane properties and
increased cellular excitability, consistent with the reduction of
HCN1 protein expression in the shRNA-HCN1-infected CA1
region. Remarkably, rats infused with lentiviral shRNA-HCN1 in
the dorsal CA1 regions displayed anxiolytic- and antidepres-
sant-like behaviors associated with upregulation of BDNF and504 Neuron 75, 503–516, August 9, 2012 ª2012 Elsevier Inc.mTOR signaling. We further found that
knockdown of HCN1 in the dorsal CA1
region resulted in widespread enhance-
ment of hippocampal activity using
voltage-sensitive dye (VSD) imaging,
consistent with an increase in synaptic
transmission. Taken together, knock-
down of HCN1 by lentiviral shRNA-HCN1 in the dorsal hippocampal CA1 region enhanced cellular
excitability, upregulated BDNF-mTOR signaling, increased
hippocampal activity, and produced anxiolytic- and antidepres-
sant-like behaviors. Our findings suggest that targeting HCN1
channels might provide an alternative therapy for treating
depression and anxiety disorders.
RESULTS
Knockdown of HCN1 Channels in the Dorsal
Hippocampal CA1 Region
Wedeveloped a lentivirus-based silencing RNA system express-
ing short hairpin RNA (shRNA) against HCN1 mRNA (Figure 1A)
to knockdown the expression level of HCN1 protein in the dorsal
hippocampal CA1 region. To achieve higher transfection effi-
ciency, we used the U6 promoter to drive shRNA expression.
Therefore, we first confirmed that HCN1 subunits are only
expressed in neurons and not glia cells (see Figure S1 available
online). Given that the brain parenchyma in young animals has
more extracellular space to provide better spread of lentiviral
particles (Thorne and Nicholson, 2006; Zhao et al., 2008), we
used 4- to 5-week-old rats for infusion of lentivirus in this study.
Lentivirus expressing shRNA-HCN1 was infused in the CA1
region of the dorsal hippocampus, which expressed on 7 days
postinfusion (DPI) and up to at least six months (Figure 1B) and
spread mediolaterally (about 0.7–1.0 mm) and anteroposteriorly
(about 1.2–1.6 mm) (Figure 1C). We quantified the local silencing
efficiency of HCN1 protein by immunohistochemistry and
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Figure 2. Specific Knockdown of HCN1 by Lentiviral-shRNA-HCN1 in the CA1 Region of the Dorsal Hippocampus
(A) Seventy micrometer thick dorsal hippocampal slices from non-infected rats were immunolabeled with HCN1 (a1, a2), HCN2 (a4), and dendritic marker MAP2
(a3). a2 and a3 are enlarged from the dashed box.
(B) In the shRNA-control-infected dorsal hippocampal CA1 region, protein expression of HCN1 (b1, b3), HCN2 (b6), and MAP2 (b4) were similar to noninfected
group. b3, b4, and b5 are enlarged from the dashed box. The labeling of HCN1 (b1) and HCN2 protein (b6) were superimposed with GFP expression in b2 and b7.
The arrows indicate lentivirus-infected CA1 region.
(C) In the ShRNA-HCN1-infected dorsal hippocampal CA1 region, protein expression of HCN1 (c1, c3) was significantly reduced without affecting the expression
of HCN2 (c6) and MAP2 (c4). c3, c4, and c5 are enlarged from the dashed box in c1. The labeling of HCN1 (c1) and HCN2 protein (c6) were superimposed with
GFP expression in c2 and c7.
(D) Quantification of HCN1 and HCN2 protein expression from the perisomatic region to the distal dendritic area in the CA1 region. The gray shade indicates
significant difference in HCN1 protein expression between shRNA-HCN1-infected region (n = 3) and noninfected (n = 3) or shRNA-control-infected regions (n = 3)
(unpaired t test). There was no significant difference in HCN2 protein expression from the perisomatic region to the distal dendritic area in the CA1 region
(unpaired t test).
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HCN1 Silencing Reduces Anxiety and Depressionwestern blotting. The HCN1 protein expression was significantly
decreased without alteration in HCN2 and MAP2 protein
expression in the shRNA-HCN1-infected region as compared
to non-infected or shRNA-control-infected CA1 regions (Figures
2A–2D). Quantification of protein expression from isolated lenti-
viral shRNA-HCN1-infected dorsal CA1 region showed a 58%
reduction in HCN1 protein expression without change in HCN2
and b-tubulin protein expression as compared to shRNA-
control-infected region (Figure 2E), suggesting specificity for
knockdown of HCN1 channels.
To determine whether silencing ofHCN1 gene had an effect on
the physiology of the dorsal CA1 pyramidal neurons, Ih-sensitive
electrophysiological parameters were measured using the
whole-cell current-clamp method (Narayanan and Johnston,
2007; Figures 3 and S2). ShRNA-HCN1-infected CA1 pyramidal
neurons had hyperpolarized resting membrane potentials (Fig-
ures 3C), higher steady-state input resistance (Figure 3D), and
slower membrane time constant (Figure 3E) than noninfected
or shRNA-control-infected CA1 pyramidal neurons. For proper
comparison between groups, we held membrane potentials
at 65 mV with current injection and compared electrophysio-
logical properties (Figures 4 and S3). ShRNA-HCN1-infected
CA1 pyramidal neurons had less voltage sag (Figure 4A) and
lower resonance frequency (Figure 4B) compared to noninfected
or shRNA-control-infected CA1 pyramidal neurons. In addition,
shRNA-HCN1-infected CA1 pyramidal neurons generated more
action potentials in response to depolarizing current steps
(30–300 pA in 30 pA increments for 750ms) (Figure 4C), suggest-
ing increased cellular excitability (Shah et al., 2004). Similar
results, however, were also obtainedwith neurons at their normal
resting potentials (Figure S2). To examine subthreshold synaptic
integration (aEPSP), the response to repetitive current injections
similar to multiple excitatory postsynaptic currents were
measured using a train of 5 alpha current injections (a = 0.1,
20Hz) (Brager and Johnston, 2007; Dembrowet al., 2010; Poolos
et al., 2002). ShRNA-HCN1-infected CA1 pyramidal neurons had
larger aEPSP summation than noninfected or shRNA-control-in-
fected CA1 pyramidal neurons (Figure 4D). In agreement with our
biochemical results, these data indicate that silencing of the
HCN1 gene by shRNA-HCN1 produced electrophysiological
changes consistent with a reduction in Ih.
Knockdown of HCN1 in Dorsal Hippocampus Exerted
Anxiolytic-like Effects
To test whether HCN1 gene silencing in the dorsal hippocampus
affected locomotion and anxiety, rats infused bilaterally with
lentivirus expressing either shRNA-control or shRNA-HCN1
were examined in the open field test (OFT). The OFT is a behav-
ioral test for assessing anxiety level and exploration activity in
rats (Borelli et al., 2004; Liu et al., 2010; Prut and Belzung,
2003). As a control experiment, we tested one anxiolytic drug,
diazepam, and compared the results with saline- and vehicle-(E) Western blotting of shRNA-control-infected (n = 7) and shRNA-HCN1-infected
The protein expression of HCN1 andHCN2were quantified and normalized by b-tu
shRNA-control-infected and shRNA-HCN1-infected regions. Data are expressed
lentiviral-shRNA-control-infected group.
SO, stratum oriens; SP, stratum pyramidale; SR, stratum radiatum; SLM, stratum
506 Neuron 75, 503–516, August 9, 2012 ª2012 Elsevier Inc.treated rats. Rats that did not receive lentiviral-shRNA infusions
were placed into the open field arena 30 min after i.p. injection of
saline, vehicle (0.5%Tween 20 in saline), or diazepam (1.0mg/kg
in vehicle solution). Diazepam-treated rats displayed anxiolytic-
like behaviors as defined by increased number of center square
entries (Figure 5C), duration of center square entries (Figure 5D)
and distance traveled in the center square (Figure 5E) compared
to saline-treated or vehicle-treated rats, confirming anxiolytic-
like behaviors in this behavior paradigm (see also Figure S4).
Surprisingly, rats infused with lentiviral-shRNA-HCN1 into the
dorsal CA1 region displayed significantly larger number of center
square entries (Figure 5C), longer duration of center square
entries (Figure 5D), and longer distance traveled in the center
square (Figure 5E) compared to shRNA-control-infected rats,
indicating less anxiety-like behavior in shRNA-HCN1-infected
animals. For exploration activity, diazepam-treated rats showed
significantly increased total distance (Figures 5B and 5F),
consistent with diazepam-induced hyperexploration (Ennaceur
et al., 2010). Like diazepam-treated rats, shRNA-HCN1-infected
rats also showed significantly longer total distance traveled than
shRNA-control-infected rats (Figures 5B and 5F), indicating
more exploration in the novel open field environment. To further
confirm the anxiolytic-like effect of HCN1 knockdown in the
dorsal CA1 region, we used an elevated plus maze (EPM) test
to assess anxiety level of these animals. The EPM test is a phar-
macologically validated behavioral test for evaluating anxiety
responses of rodents (Pellow et al., 1985). Rats were allowed
to explore on the elevated plus maze 30 min after i.p. injection
of saline, vehicle (0.5% Tween 20 in saline), or diazepam
(1.0 mg/kg in vehicle solution) for 6 min. Diazepam-injected
rats displayed anxiolytic-like behaviors as defined by increased
percentage of time spent in open arms (Figure 5H) without signif-
icant change in total arm entries (Figure 5I), confirming anxio-
lytic-like behaviors in this paradigm. Like diazepam-treated
rats, shRNA-HCN1-infected rats displayed significant increase
in the percentage of time spent in open arms (Figure 5H) without
significant alteration in total arm entries (Figures 5I and S5)
compared to shRNA-control-infected rats, indicating anxio-
lytic-like behavior. Taken together, knockdown of HCN1 in the
CA1 region of the dorsal hippocampus produced anxiolytic-like
effects in the open field test and the elevated plus maze test.
Knockdown of HCN1 in Dorsal Hippocampus Produced
Antidepressant-like Effects
The modified forced swim test (FST) is used to screen antide-
pressant effects in rats and mice (Lucki, 1997). Animals sub-
jected to an inescapable stress environment typically exhibit
two different behaviors—active activity (swimming and climbing)
and passive activity (immobility) (Lucki, 1997). Passive activity
can thus be an indicator of behavioral despair in this paradigm
(Porsolt et al., 1977). This passive activity can be reduced by
acute or chronic treatment with clinical antidepressant drugs(n = 7) CA1 lysates with antibodies against HCN1, HCN2, b-actin, and b-tubulin.
bulin. The right displays the summary of HCN1 andHCN2 protein expression in
as mean ± SEM; **p < 0.01, and ***p < 0.001 compared with non-infected or
lacunosum moleculare.
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Figure 3. Alteration in IntrinsicMembrane Properties byKnockdown
of HCN1 in the Dorsal CA1 Pyramidal Neurons
(A) Photomicrograph of a representative recorded lentivirus-infected dorsal
CA1 pyramidal neurons. The left displays photomicrograph of lentivirus-
infected dorsal hippocampal CA1 region. The right enlarged from the dashed
box. The arrow indicates the recorded pyramidal neuron.
(B) Representative voltage responses with step current commands ranging
from 150 pA to +10 pA (D = 20 pA) at resting membrane potential.
(C) ShRNA-HCN1-infected CA1 pyramidal neurons (n = 9) displayed hyper-
polarized membrane potential as compared to noninfected (n = 7) or shRNA-
control-infected (n = 8) pyramidal neurons.
(D) Knockdown of HCN1 in the dorsal CA1 pyramidal neurons (n = 9) resulted in
higher input resistance than noninfected (n = 7) or shRNA-control-infected
(n = 8) pyramidal neurons.
(E) ShRNA-HCN1-infected pyramidal neurons (n = 4) displayed slower time
constant compared to noninfected (n = 3) or shRNA-control-infected (n = 4)
pyramidal neurons. The left displays representative traces and current
commands. ShRNA-HCN1-infected neurons were comparedwith noninfected
or shRNA-control-infected CA1 pyramidal neurons. Data are expressed as
mean ± SEM; *p < 0.05 and ***p < 0.001.
See also Figure S2 and Tables S1 and S2.
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HCN1 Silencing Reduces Anxiety and Depression(Liu et al., 2010; Lu et al., 2006). We replicated this finding in rats
treated with either a sub-anesthetic dose of ketamine (15 mg/kg
i.p.) or fluoxetine (10mg/kg i.p.). Fluoxetine and ketamine treated
rats displayed significantly reduced duration of passive activity
in the forced swim test (Figure 6A) compared to saline-treatedrats, confirming antidepressant-like effects of these compounds
in this behavioral paradigm. Additionally, diazepam did not have
antidepressant-like effects in forced swim test (Figure 6B) even
though it showed hyperexploration in OFT, suggesting speci-
ficity of this behavioral test (Figure S6). To determine whether
knockdown of HCN1 in the dorsal CA1 region can produce anti-
depressant-like effects, rats were microinjected bilaterally with
lentivirus expressing either shRNA-control or shRNA-HCN1.
Similar to fluoxetine or ketamine treatment, knockdown of
HCN1 was associated with an antidepressant-like effect
compared with shRNA-control-infected animals (Figure 6C).
Because shRNA-HCN1-infected rats displayed higher explora-
tion activity (Figures 5B and 5F) in the open field test, we further
analyzed whether there was a relationship between exploration
activity and duration of passive activity. We found, however,
that there was no correlation between passive activity in FST
and exploration activity in OFT (Figure 6D), suggesting specificity
of antidepressant-like effects by knockdown of HCN1 in the
dorsal hippocampal CA1 region.
Enhancement of Dorsal Hippocampal Activity and
Upregulation of BDNF-mTOR Signaling in the Dorsal
Hippocampal CA1 Region by Knockdown of HCN1
Patients with treatment-resistant depression have pathologically
altered activity in the limbic-cortical area (Mayberg et al., 2005).
Animal models of depression induced by chronic mild stress
display an increase in the ventral CA1 activity. This could be
reversed by fluoxetine, highlighting the significance of hippo-
campal activity in the treatment of depression (Airan et al.,
2007). Because genetic silencing of HCN1 gene in a small region
of the dorsal hippocampal CA1 region produced anxiolytic- and
antidepressant-like effects, it is possible that chronic knock-
down of HCN1 could cause changes in hippocampal activity.
We used voltage-sensitive dye (VSD) imaging to determine
whether a localized, chronic knockdown of HCN1 can change
hippocampal activity. We placed a stimulating electrode in the
stratum radiatum (SR), near the border between the CA1 and
CA2 regions to activate the Schaffer collaterals (Chang et al.,
2007). Both VSD optical signals and extracellular field potentials
were recorded in the SR of the CA1 region (Figures 7B and 7C).
Knockdown of HCN1 led to enhanced VSD optical signals in
response to a burst of stimuli (five 0.2 ms current pulses at
100 Hz, 100 mA) as compared to shRNA-control-infected group
(Figure 7D), indicating widespread enhancement of hippo-
campal activity. At the area 500 mm away from the stimulating
electrode, where the recording electrode was placed, the peak
amplitude of VSD optical signals in shRNA-HCN1-infected slices
were significantly larger than those evoked in shRNA-control-
infected slices (Figures 7F and 7G). To compare VSD optical
signals in response to a similar number of activated Schaffer
collaterals, we grouped data with a fixed range of fiber volley
amplitude (FV, 0.1–0.15 mV) and, consistently, the shRNA-
HCN1-infected group showed significantly increased VSD
optical signals as compared to shRNA-control-infected group
(Figure 7E). It has been demonstrated that VSDoptical signals re-
flecting membrane depolarization of postsynaptic neurons are
correlated with extracellular field potentials (Tominaga et al.,
2000). The widespread enhancement of VSD optical signals inNeuron 75, 503–516, August 9, 2012 ª2012 Elsevier Inc. 507
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Figure 4. Knockdown of HCN1 Induced Physiological Changes Consistent with Reduction of Ih in the Dorsal CA1 Pyramidal Neurons
For proper comparison between groups, CA1 pyramidal neurons were held at 65 mV.
(A) shRNA-HCN1-infected CA1 pyramidal neurons (n = 10) showed less voltage sag compared to noninfected (n = 7) or shRNA-control-infected pyramidal
neurons (n = 9). The top are representative voltage traces and current commands. The sag is defined as the ratio of the maximum hyperpolarization (Max) to the
steady-state hyperpolarization (SS).
(B) shRNA-HCN1-infected pyramidal neurons (n = 10) had lower membrane resonance frequency than noninfected (n = 6) or shRNA-control-infected pyramidal
neurons (n = 6). The top are representative voltage traces and current commands. The arrows point to the maximum depolarization. The bottom left displays the
profile of impedance amplitude. The resonance frequencies are marked by vertical lines.
(C) shRNA-HCN1-infected pyramidal neurons (n = 10) had more action potentials than noninfected (n = 6) or shRNA-control-infected pyramidal neurons (n = 7).
The left are representative voltage traces.
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HCN1 Silencing Reduces Anxiety and Depressionthe CA1 region of shRNA-HCN1-infected slices suggested that
basal synaptic transmission might have been changed. Indeed,
we found that there were significant differences in the slope of
field potentials without change in the amplitude of presynaptic
fiber volleys between shRNA-control- and shRNA-HCN1-
infected groups (Figures 8A and S7), indicating enhanced
synaptic transmission in the shRNA-HCN1-infected CA1 region.
The paired-pulse ratio (PPR) was not significantly different
between shRNA-control- and shRNA-HCN1-infected slices,
suggesting no significant difference in presynaptic neurotrans-
mitter release probability between these two groups (Figure 8B).
Recently, it has been reported that a low dose of ketamine
increasedBDNFprotein synthesis and activatedmTOR signaling
pathway, leading to antidepressant-like effect (Autry et al., 2011;
Li et al., 2010). In addition, ketamine is also known as an inhibitor
of HCN1 channels (Chen et al., 2009). Because we observed
that knockdown of HCN1 channels in the dorsal hippocampal
CA1 region produced antidepressant-like effect, it is possible
that this manipulation also altered BDNF-mTOR signaling
pathway. Indeed, knockdown of HCN1 in the dorsal CA1 region
resulted in significant increase in mature BDNF expression and
phosphorylation of mTOR in dorsal hippocampus (Figure 8C),
suggesting possible cellular mechanisms underlying the antide-
pressant-like effect. Taken together, knockdown of HCN1 in
the dorsal hippocampal CA1 region resulted in widespread
enhancement of VSD optical signals with an enhancement in
synaptic transmission, which is likely associated with the upre-
gulation of BDNF-mTOR signaling.
DISCUSSION
We used a lentiviral shRNA system to locally silence HCN1 gene
in the dorsal hippocampus. This resulted in altered physiological
properties of individual CA1 neurons, increased synaptic trans-
mission, higher hippocampal CA1 activity during stimulation,
and upregulated BDNF-mTOR signaling at the hippocampal
network level, and produced anxiolytic- and antidepressant-
like behavioral effects in rats.
Lewis et al. (2011) reported that three different lines of
knockout mice (HCN1, HCN2, and TRIP8b) with elimination or
reduction of functional Ih displayed antidepressant-like behav-
iors. To determine which brain regions are important for this
antidepressant-like behavior, we developed a lentiviral shRNA-
HCN1 system that allowed for focused silencing of the HCN1
gene in a small population of neurons. A single infusion of lenti-
virus expressing shRNA-HCN1 infected about one-third of the
dorsal CA1 region and produced a decrease in HCN1 protein
expression and physiological changes consistent with the
reduction of Ih. Knockdown of HCN1 channels in the CA1 pyra-
midal neurons led to changes in the intrinsic membrane proper-
ties as well as an increase in cellular excitability measured as
a change in the number of action potentials elicited by defined
current injections.(D) Knockdown of HCN1 in dorsal CA1 pyramidal neurons (n = 9) resulted in hig
infected pyramidal neurons (n = 6). The left are representative voltage traces and
and ***p < 0.001 compared with noninfected or shRNA-control-infected CA1 pyr
See also Figure S3 and Table S2.Anxiolytic- and Antidepressant-like Effects by
Knockdown of HCN1 in the Dorsal Hippocampus
Anxiety- and depression-like symptoms induced by chronic mild
stress can be reversed by acute or chronic administration of anti-
depressant drugs (Liu et al., 2010; Lu et al., 2006). In a clinical
study, chronic administration of serotonin selective reuptake
inhibitors (SSRIs) showed therapeutic effects in patients with
general anxiety disorder (Ball et al., 2005). Our behavioral data
indicated that knockdown of HCN1 in the dorsal hippocampal
CA1 region promoted both anxiolytic- and antidepressant-like
effects. In the open field test, shRNA-HCN1-infected rats
showed significantly more center square entries, longer dura-
tion, and longer traveled distance in the center square, and
increased open arm time and entries in the elevated plus maze
test compared to shRNA-control-infected rats. In contrast,
TRIP8b and HCN1 knockout mice lacking functional Ih did not
display anxiolytic-like behaviors in the elevated plus maze test
and dark/light box test (Lewis et al., 2011). One possibility is
that whole-brain deletion of TRIP8b or HCN1 gene might have
masked the anxiolytic-like effects due to the lack of functional
HCN1 protein in other brain regions that are involved in different
physiological functions and behavior phenotypes (Nolan et al.,
2003, 2004;Wanget al., 2007). Another possibility is that absence
of functional HCN1 protein during development might have
evoked some compensatory mechanisms, which mask the anxi-
olytic-like effects of HCN1 gene deletion in the dorsal hippo-
campal CA1 region. The observation that knockdown of HCN1
in the dorsal hippocampal CA1 region produced antidepres-
sant-like effects in the forced swim test was similar to that previ-
ously found from global knockout animals (Lewis et al., 2011).
TRIP8b knockout mice lacking functional Ih showed antidepres-
sant-like behavior as indicated by significantly reduced immo-
bility time in the forced swim and tail suspension tests. This is in
general agreement with antidepressant-like effects by knock-
down of HCN1 in the dorsal hippocampal CA1 region. Because
lentiviral shRNA-HCN1-infected rats displayed increased explo-
ration during 5 min open field test, it is possible that increased
exploration attempts might affect passive activity in the forced
swim test. However, linear regression analysis from behavior
test results indicated that there were no correlation between
exploration activity in OFT and duration of passive activity in
FST, suggesting specificity for antidepressant-like effect of
HCN1 knockdown in the dorsal hippocampal CA1 region.
Widespread Enhancement of Hippocampal Activity
by Knockdown of HCN1 in Dorsal CA1 Region
Why does knockdown of HCN1 in a small CA1 region of the
dorsal hippocampus produce anxiolytic- and antidepressant-
like effects? It is becoming increasingly clear that small popula-
tions of neurons in specific regions can mediate certain behav-
iors (Han et al., 2009; Silva et al., 2009). Moreover, it has been
shown that chronic electrical stimulation in limbic-cortical region
from patients with treatment-resistant depression reducedher aEPSP summation as compared to noninfected (n = 6) or shRNA-control-
current commands. Data are expressed as mean ± SEM; *p < 0.05, **p < 0.01,
amidal neurons.
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Figure 5. Knockdown of HCN1 by Lentiviral shRNA-HCN1 in the CA1 Region of the Dorsal Hippocampus Produced Anxiolytic-like Effects in
the Open Field Test and Elevated Plus Maze Test
(A) Representative coronal sections of the brains display the areas infected by lentivirus (green).
(B) Representative video tracking images during the last 5 min of open field test of age-matched individual rats treated with saline (i.p.), vehicle (i.p.), diazepam
(1 mg/kg i.p.), or infected with lentiviral shRNA-control or shRNA-HCN1. During the open field test, the number of center square entries (C), the duration (D), and
the traveled distance (E) in the center square were measured. Like diazepam-treated rats, shRNA-HCN1-infected rats showed significantly increased center
square entries, center time, and center distance compared to shRNA-control-infected rats, indicating anxiolytic-like behaviors.
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Figure 6. Knockdown of HCN1 by Lentiviral
shRNA-HCN1 in the CA1 Region of the
Dorsal Hippocampus Promoted Antidepres-
sant-like Effects in the Forced Swim Test
(A) Ten- to twelve-week-old rats were treated with
saline i.p. (n = 17), 10 mg/kg fluoxetine i.p. (n = 13),
or 15mg/kg ketamine i.p. (n = 13) 30min before the
forced swim test as a positive control. Rats treated
with fluoxetine or ketamine displayed significantly
less passive activity time compared to rats treated
with saline.
(B) Diazepam-treated rats (1mg/kg i.p., n = 12) had
no effect on the forced swim test compared to
vehicle-treated rats (n = 13).
(C) ShRNA-HCN1-infected rats (n = 18) displayed
significantly less passive activity time compared to
shRNA-control-infected rats (n = 17). Behavior
despair as indicated by passive activity time was
determined in the last 4 min of the forced swim
test.
(D) There was no significant correlation between
the passive activity time (s) in the forced swim test
and the total traveled distance (inch) in the open
field test analyzed with linear regression. Data are
expressed as mean ± SEM; *p < 0.05, **p < 0.01,
and ***p < 0.001.
See also Figure S6 and Table S5.
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HCN1 Silencing Reduces Anxiety and Depressionpathologically elevated metabolic activity, implying that alterna-
tion in limbic-cortical activity may be involved in this treatment of
severe depression (Mayberg, 2003; Mayberg et al., 2005). In
a functional neuroimaging study, patients with severe depres-
sion showed reduced posterior hippocampal volume, suggest-
ing the posterior hippocampus, the equivalent of dorsal hippo-
campus in rodents, might be involved in both affective status
and spatial learning in humans (Campbell and Macqueen,
2004). Indeed, depressed patients showed deficits in spatial
learning and memory assessed by a virtual navigation task as
compared to healthy subjects (Gould et al., 2007). In a nonclinical
study, Airan et al. (2007) showed that animal models of depres-
sion induced by chronic mild stress displayed increased ventral
CA1 activity using voltage-sensitive dye imaging, which can be
reversed by clinical antidepressant drugs delivered by i.p. injec-
tion, indicating that modulation of hippocampal activity might be
required for the treatment of depression. In our experiments,
knockdown of HCN1 in the dorsal hippocampal CA1 region re-
sulted in a widespread increase of VSD optical signals in
response to afferent stimulation, indicating an enhancement of(F) Like diazepam-induced hyperexploration in the open field test, shRNA-HCN1-
control-infected rats for the last 5 min of the test.
(G) Representative video tracking images during the 6 min of elevated plus ma
diazepam (i.p.), or infected with lentiviral shRNA-control or shRNA-HCN1. The tra
reliably recognize the body center (shaded boxes). During the elevated plus m
diazepam-induced increase in the percentage of open arm time, shRNA-HCN
compared to shRNA-control-infected rats.
(I) There is no significant difference in total arm entries between groups. Data are
and ***p < 0.001.
See also Figures S4 and S5 and Tables S3 and S4.dorsal hippocampal activity. This discrepancy might be related
to brain region, dorsal hippocampus versus ventral hippo-
campus, or specificity, knockdown of HCN1 versus antidepres-
sant drug delivered by i.p. injection. Another possibility is that we
consistently placed the stimulating electrode in the middle of
stratum radiatum, close to the border between CA1 and CA2
regions, to activate Shaffer collaterals. In contrast to our exper-
imental configuration, the stratum pyramidale was targeted for
stimulation in Airan et al.’s study, which might have activated
significantly more inhibitory axons.
Because we observed behavioral changeswith the expression
of shRNA-HCN1 in a small CA1 region of the dorsal hippo-
campus, one concern is that lentivirus might have been
transported retrogradely to other brain regions. We found no
evidence, however, of GFP-positive cells outside of the dorsal
hippocampus including the dorsal raphe containing serotonergic
cell bodies and the locus coeruleus containing noradrenergic cell
bodies (data not shown), suggesting that anxiolytic- and antide-
pressant-like behaviors are due to knockdown of HCN1
channels in the dorsal hippocampal CA1 region. This isinfected rats also showed increased exploration activity compared to shRNA-
ze test of age-matched individual rats treated with saline (i.p.), vehicle (i.p.),
ces do not include locations near the end of closed arms since it is too dim to
aze test, the percentage of open arm time (H) was measured. Similar to the
1-infected rats displayed significantly higher percentage of open arm time
expressed as mean ± SEM with significance indicated by *p < 0.05, **p < 0.01,
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Figure 7. Knockdown of HCN1 Enhanced
Voltage-Sensitive Dye (VSD) Optical Signals
in the Dorsal Hippocampal CA1 Region
(A) Schematic illustration of the dorsal hippo-
campal slices prepared from lentivirus-infected
animals.
(B) Photomicrograph of a representative hippo-
campal slice displays the location of the stimu-
lating electrode, the recording electrode, and the
regions of interest (ROIs). The size of ROIs is 2003
200 mm. The stimulating electrode was placed in
the stratum radiatum (SR) close to the CA2 region
and the recording electrode was placed in the SR
of CA1 region, 500 mm away from the stimulating
electrode.
(C) A representative image displays the lentivirus-
infected dorsal CA1 region.
(D) VSD optical signals were widely increased
along the CA1 axis in response to a train of stimuli
(five, 0.2 ms current pulses at 100 Hz, 100 mA).
The top are representative maximal VSD optical
signals (color scale: 0%–0.6%).
(E) Knockdown of HCN1 enhanced widespread
VSD optical signals within a fixed range of fiber
volley amplitude (0.1–0.15 mV) compared to
shRNA-control-infected group.
(F) Representative traces of VSD optical signals
from the ROIs, 500 mm away from the stimulating
electrode, in response to a train of stimuli (five
0.2 ms current pulses at 100 Hz, 20–100 mA).
(G) Knockdown of HCN1 enhanced VSD optical
signals at the ROI 500 mm from the stimulating
electrode in response to a train of stimuli (five
0.2 ms current pulses at 100 Hz, 20–100 mA). Data
are expressed as mean ± SEM; *p < 0.05, **p <
0.01, and ***p < 0.001 compared with shRNA-
control-infected group.
See also Figure S7.
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HCN1 Silencing Reduces Anxiety and Depressionconsistent with the report that VSV-G pseudotyped lentivirus did
not transport retrogradely in the brain (Louboutin et al., 2007),
suggesting local expression in the primary injection area. It has
been reported that hippocampal theta waves propagate along
the septotemporal axis (Lubenov and Siapas, 2009). Thus, we
cannot rule out the possibility that knockdown of HCN1 channels
in the dorsal hippocampus influenced the initiation and propaga-
tion of theta waves to the ventral region and thereby contributing
to the affective state of animals.
Chen et al. (2009) reported that ketamine, an NMDA receptor
antagonist and clinical anesthetic, inhibited h-channels and
reduced total Ih conductance in cortical and CA1 pyramidal
neurons by acting on HCN1 subunits. In agreement with our
results, a subanesthetic dose of ketamine, which would inhibit
HCN1 containing h channels, produced early-onset and long-
lasting therapeutic antidepressant effects in both animal models512 Neuron 75, 503–516, August 9, 2012 ª2012 Elsevier Inc.of depression and in patients with treat-
ment-resistant depression (Autry et al.,
2011; Berman et al., 2000; Li et al.,
2010). This ketamine-mediated antide-
pressant-like effect depends on BDNF
protein synthesis and activation ofmTOR pathway (Autry et al., 2011; Li et al., 2010). Consistent
with these findings, lentiviral shRNA-HCN1-infected dorsal
CA1 region showed significantly increased mature BDNF protein
expression and phosphorylation of mTOR, indicating upregula-
tion of BDNF-mTOR signaling pathway. This upregulation of
BDNF-mTOR signaling may be mediating the enhancement of
hippocampal activity, the increase in synaptic transmission
and the alteration in behaviors.
Ketamine is known as a psychotomimetic agent producing
hallucination, delirium, and confusion (Remerand et al., 2007;
Webster and Walker, 2006). In addition, chronic administration
of clinical antidepressant drugs increased the risk of seizures
in depressed patients (Alldredge, 1999; Peck et al., 1983; Salz-
berg and Vajda, 2001). Thus, another alternative therapy to treat
depression is invaluable. In our VSD imaging and field potential
recording, we did not observe any abnormal epileptic-like
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Figure 8. Enhancement of Synaptic Trans-
mission and BDNF-mTOR Signaling by
Knockdown of HCN1 in the Dorsal CA1
Region
(A) Representative traces of field excitatory post-
synaptic potentials (fEPSPs) recorded in the
median stratum radiatum (SR) of the CA1 region in
response to a single stimulation (100 mA, arrow).
The slope of fEPSP as a function of stimulation
intensity from 20 mA to 100 mA showed significant
difference between shRNA-control and shRNA-
HCN1-infected dorsal hippocampal CA1 regions
without change in the amplitude of presynaptic
fiber volley.
(B) Representative traces of fEPSPs evoked by
paired pulses at four inter-stimulus intervals (ISI;
20 ms, 50 ms, 100 ms, and 200 ms) in shRNA-
control and shRNA-HCN1-infected dorsal hippo-
campal CA1 region. Paired-pulse ratio was not
significantly different between shRNA-control-
and shRNA-HCN1-infected dorsal hippocampal
CA1 regions.
(C) Mature BDNF (mBDNF) protein expression was
significantly increased in shRNA-HCN1-infected
dorsal CA1 region (n = 3) compared to shRNA-
control infected group (n = 3). mBDNF protein
expression was normalized by b-tubulin. Knock-
down of HCN1 in dorsal CA1 region (n = 6)
increased phosphorylation of mTOR compared to
shRNA-control-infected group (n = 6). Phospho-
mTOR protein expression was normalized by total
mTOR and b-tubulin. Data are expressed as
mean ± SEM; **p < 0.01.
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HCN1 Silencing Reduces Anxiety and Depressionactivity in the shRNA-HCN1-infected CA1 region, suggesting
local silencing of HCN1 expression might provide an alternative
treatment to existing pharmacological interventions for treating
depression and anxiety disorders.
EXPERIMENTAL PROCEDURES
Animals
Male Sprague-Dawley rats (4–12 weeks old) were used for these experiments.
Rats were housed 2–3 per cage in a temperature (25 5C)- and light (12 hr light/
12 hr dark cycles)-controlled room. All procedures were carried out in accor-
dance to the University of Texas at Austin Institutional Animal Care and Use
Committee (IACUC).
Generation of Lentivirus
Lentivirus production is described in Supplemental Experimental Procedures.
Stereotaxic Microinjection
Stereotaxic microinjection is described in Supplemental Experimental
Procedures.Neuron 75, 503–51Biochemical Assay
Western blotting and immunohistochemistry
are described in Supplemental Experimental
Procedures.
Dorsal Hippocampal Slice Preparation
and Electrophysiology
Four- to five-week-old rats were bilaterally micro-
injected with lentivirus expressing shRNA-controlor shRNA-HCN1 in the dorsal hippocampal CA1 region. After behavior test,
dorsal hippocampal slices (350 mm) were prepared from 10- to 12-week-old
lentivirus-infected male Sprague-Dawley rats. Then slices were transferred
to a holding chamber for 20–30 min at 35C containing (in mM) 125 NaCl,
2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 2 CaCl2, 2 MgCl2, 10 dextrose, 1.3 ascor-
bic acid, and 3 sodium pyruvate, bubbled with 95% O2-5% CO2. Whole-cell
current-clamp recordings were performed on slices submerged in a recording
chamber filled with aCSF heated to 32C–34C flowing at a rate of 1 to
2 ml/min. ACSF contained (in mM) 125 NaCl, 2.5 KCl, 1.25 NaH2PO4,
25 NaHCO3, 2 CaCl2, 1 MgCl2, and 12.5 dextrose, bubbled with 95%
O2-5% CO2. Lentivirus-infected CA1 pyramidal neurons were visualized using
a microscope (Zeiss Axioskop) fitted with differential interference contrast
optics and a GFP filter set (Stuart et al., 1993). Patch pipettes (4–7 MU) were
prepared with capillary glass (external diameter 1.65 mm, World Precision
Instruments) using Flaming/Brown micropipette puller and filled with an
internal solution containing (in mM) 120 K-gluconate, 20 KCl, 10 HEPES,
4 NaCl, 7 K2-phosphocreatine, 4 Mg-ATP, 0.3 Na-GTP (pH 7.3 with KOH).
Neurobiotin (Vector Labs) was used (0.1%–0.2%) for subsequent histological
processing (DAB staining). Data were acquired with a Dagan BVC-700A
amplifier (Dagan, Minneapolis, MN) and were filtered at 3 kHz, sampled at
10 kHz, and digitized by an ITC-18 interface (Instructech Corporation, Port6, August 9, 2012 ª2012 Elsevier Inc. 513
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HCN1 Silencing Reduces Anxiety and DepressionWashington, NY) connected to a computer running custom software written in
IGOR Pro (Wavemetrics). Data analyses were also performed with custom
software written in IGOR Pro. The experiments were performed under blind
conditions. No correction for liquid junction potential (8 mV).
Behavioral Procedures
One hundred twenty-two rats (9–12 weeks old) were assigned into seven
groups as follows: group I, saline i.p. injected (n = 17); group II, vehicle
(0.5% Tween 20 in saline) i.p. injected (n = 13); group III, diazepam i.p. injected
(1 mg/kg, n = 18); group IV, ketamine i.p. injected (15 mg/kg, n = 13); group V,
fluoxetine i.p. injected (10 mg/kg, n = 13); group VI, lentivirus expressing
shRNA-control microinjected into the dorsal hippocampal CA1 region (n =
24); group VII, lentivirus expressing shRNA-HCN1microinjected into the dorsal
hippocampal CA1 region (n = 24). All behavior evaluations were done blindly.
Experiment was performed in noise- and light-controlled behavior room.
Custom written programs were used to analyze animal behaviors (http://clm.
utexas.edu/djlab).
Open Field Test
The apparatus was consisted of opaque- and matte-finished black acrylic
sheet (36’’ 3 36’’ 3 24’’). Each rat was randomly assigned and placed into
the center of the field following 30 min saline, vehicle, and diazepam i.p. injec-
tion. Behavior in the open field arena was recorded for 6 min using a CCD
camera. The surface of the open field arena was cleaned with 70% EtOH in
order to remove permeated odors by previous animals after each trial. To
analyze behaviors for the last five minutes, the open field arena was divided
into 9 equal-size squares (12’’ by 12’’). Basal exploration activity was
measured by total traveled distance (inch) and anxiety level was assessed
by the number of center square entries, the duration, and the traveled distance
in the center square. A line crossing was defined as the body center crosses
a line.
Elevated Plus Maze Test
The apparatus was made of black acrylic sheet. Four arms (50 cm long and
10 cm wide) are connected and elevated to a height of 50 cm from the floor.
Two arms are open (open arms) and the other two arms are enclosed within
40 cm walls. Each rat was placed into the intersection of the four arms (center
area) 30 min following saline, vehicle, or diazepam i.p. injection. Behavior in
elevated plus maze was recorded for 6 min using a CCD camera. The surface
of the elevated plus maze was cleaned with 70% EtOH in order to remove
permeated odors by previous animals after each trial. To analyze behavior
test for 6 min, the number of arm entries and the percentage of open arm
time (duration in open arm/total time) were assessed. Arm entry was defined
as 50% of the body being positioned within the arm.
Forced Swim Test
The tank is made of transparent Plexiglas cylinder (80 cm tall3 30 cm in diam-
eter) filled with water (23C–24C) to a depth of 45 cm. Water in the tank was
changed after each trial. For the first exposure, rats without drug treatment
were placed in the water for 15 min (pretest session). Twenty-four hours later,
rats were placed in the water again for a 6 min session (test session) 30 min
following saline, vehicle, diazepam (1 mg/kg), ketamine (15 mg/kg), or fluoxe-
tine (10 mg/kg) i.p. injection. Forced swim test was recorded by a video
cameras positioned on the top of thewater tank. A passive activity was defined
as floating and making only those movements necessary to keep the nose
above the water. Behaviors from forced swim test was quantified by using
a time sampling technique to rate the predominant behavior over a 5 s interval
as described (Lucki, 1997) and a custom written program.
Voltage-Sensitive Dye Imaging and Extracellular Field Potential
Recording
Four- to five-week-old rats were bilaterally microinjected with lentivirus
expressing shRNA-control or shRNA-HCN1 in the dorsal hippocampal CA1
region. After behavior test, dorsal hippocampal slices (350 mm) were prepared
from 10- to 12-week-old lentivirus-infected male Sprague-Dawley rats. Slices
were stained with the voltage-sensitive dye RH-414 (Molecular Probes) for at
least 30 min (0.15 mM in aCSF). Recording pipettes (1–2 MU) were filled with
aCSF and placed in the stratum radiatum (SR) of the CA1 region. Synaptic
responses were evoked by a glass stimulating electrode placed in the stratum
radiatumnear the border between theCA1 and theCA2 regions. The filter set is514 Neuron 75, 503–516, August 9, 2012 ª2012 Elsevier Inc.consisted of a 510–560 nm excitation filter, a 590 nm longpass emission filter,
and a 590 nm longpass dichroic mirror. Optical signals were sampled at 1 kHz
with a fast CCD camera (CCD-SMQ; RedShirtImaging, GA). Custom software
written in C++ was used to control the camera, the amplifier and to analyze
the optical and field potential signals. All optical signals were displayed as
the change in fluorescence divided by resting fluorescence (DF/F). Average
of four trials was analyzed. The experiments were performed under blind
conditions.
Data Analysis
Quantification of data from immunohistochemistry and western blotting was
determined by optical density analysis using the ImageJ program. Input resis-
tance was measured by the slope of the linear fit of the V-I plot between +10
and 150 pA current injection. Voltage sag was calculated as the ratio of
the maximum voltage change to the steady-state voltage change resulting
from hyperpolarizing current injections. Slow time constant was calculated
from a double-exponential fit of the averaged voltage decay resulting from
100 trials of identical 1 ms, 400 pA current injections. Resonance frequency
was measured as the frequency of the peak impedance using a sinusoidal
current injection of constant amplitude and linearly spanning 0–15 Hz in 15 s.
Temporal summation ratio was measured as the amplitude of the fifth aEPSP
relative to the first in a train of five aEPSPs at 20 Hz ([aEPSP5 -aEPSP1]/
aEPSP1). Paired-pulse ratio (PPR) was calculated as the ratio of the slope of
the second fEPSP to the slope of the first fEPSP. The slope of fEPSP was
measured by the initial part of fEPSP (0.5 ms). Lentivirus-infected rats were
excluded from behavior results if GFP expression is not limited in the dorsal
CA1 region.
Statistical Analysis
All data were expressed as mean ± SEM. The data from whole-cell current-
clamp recordings were analyzed using unpaired t test. Unpaired t test and
one-way ANOVA were used for the analysis of behavioral results followed by
Tukey post hoc test. Two-way ANOVAwas used for the analysis of VSD optical
signals and field potentials followed by Bonferrori post hoc test. Biochemical
results were analyzed using unpaired t test. p < 0.05 was considered as statis-
tically significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, five tables, and Supple-
mental Experimental Procedures and can be found with this article online at
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